VeriKine-HS Human IFN-Alpha ELISA (All-Subtype) kits are designed to provide low pg/ml (LOQ 1.95 pg/ml) sensitivity and global IFN-Alpha subtype detection (12 of 12) in serum, plasma, and tissue culture media (TCM). As multiple IFN-Alpha (IFNa, IFN-a) species are often present in biological samples, the ability to determine the total amount of IFN-Alpha subtypes is integral to a full understanding of IFN-Alpha's role within the immune system.
Click here to see which PBL Human IFN-Alpha ELISA kit is best fit for your research need.
|
|
||
|---|---|---|
| High Sensitivity for low-level Human IFN-Alpha quantification |
1.95 - 125 pg/ml |
|
|
Human IFN-Alpha All-Subtype reactivity for total quantification |
12 of 12 |
|
| Robust Sample Matrix Compatibility | Tissue Culture Media (TCM) | TCM; EDTA-Plasma; Healthy and Autoimmune Disease Sera |
PBL's multi-subtype ELISAs (41100, 41105, 41110) detect a number of the 12 IFN-Alpha subtypes. These kits differ in three main ways from one another: (1) subtype detection (moderately sensitive for most or several IFN-Alpha subtypes), (2) assay range, and (3) matrix compatibility (TCM, serum, plasma).
Technical Literature:
- Determination of Interferons and Biomarkers in Influenza Donor Samples
- Human IFN-Alpha ELISA Plasma Matrix Study
- Human IFN-Alpha ELISA Subtype Specificity Comparison Chart